Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
SAN DIEGO, Nov. 6, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme” or the “Company”), today announced the... Read more.
Coway Announces Financial Results for Q3 FY2025
SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ — Coway Co., Ltd., the “Best Life Solution Company,” has today released its financial results for... Read more.
PrideStaff Dallas (North) Marks 25th Anniversary with $25,000 Commitment to Ally’s Wish
DALLAS, Nov. 6, 2025 /PRNewswire/ — In honor of its 25th anniversary serving the Dallas business community, PrideStaff’s North Dallas office has announced... Read more.
Front Porch Cohousing Appoints Two Strategic Advisors
Desiree Kameka Galloway and Danielle Vickers, who bring over 40 years of combined experience, will help propel the organization’s mission to create inclusive... Read more.
Material Fact: Approval of “equity swap” derivative contracts
EMBRAER S.A. Publicly Held Company CNPJ/MF 07.689.002/0001-89 NIRE 35.300.325.761 SÃO JOSÉ DOS CAMPOS, Brazil, Nov. 6, 2025 /PRNewswire/ — Embraer S.A. (“Company”)... Read more.
Medicare Expands GLP-1 Coverage as MENU ORDER AI Prepares App Store Debut for the High-Protein / GLP-1 Dining Revolution
As the only health-tech app designed specifically for GLP-1 users who dine out — and for restaurants eager to welcome them back — MENU ORDER AI combines AI-powered... Read more.
WorkBetterNow Named a 2025 Inc. Power Partner and Earns Second Consecutive Inc. 5000 Honor
NEW YORK, Nov. 6, 2025 /PRNewswire/ — WorkBetterNow (WBN), a leading provider of high-performing remote talent to U.S. businesses, is proud to announce it... Read more.
VTOMAN Launches Unbeatable Black Friday Deals with Massive Savings on Portable Power Stations
LOS ANGELES, Nov. 6, 2025 /PRNewswire/ — VTOMAN, a leading name in portable power technology, today announced its highly anticipated Black Friday Extravaganza,... Read more.
Argo Biopharma to Present Positive Phase I Results of siRNA Therapeutic BW-20805 for HAE at ACAAI 2025
SHANGHAI and BOSTON, Nov. 6, 2025 /PRNewswire/ — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics... Read more.
The ‘Stock Market for Stories’ Launches Campaign for THORPE
Verily Storyworks debuts crowdfunding THORPE, an epic original series endorsed by the Thorpe family, with public launch on November 5 DALLAS, Nov. 6, 2025 /PRNewswire/... Read more.